|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 2336 for Actb

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.023s

Categories

Category: Publication
« show all
Type Details Score
Publication
18443199 | J:141321
First Author: Klöting N
Year: 2008
Journal: Diabetes
Title: Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth.
Volume: 57
Issue: 8
Pages: 2074-82
•
•
•
•
•
Publication
29233735 | J:306784
 
First Author: Alves S
Year: 2018
Journal: Int J Biochem Cell Biol
Title: N-terminal acetylation modulates Bax targeting to mitochondria.
Volume: 95
Pages: 35-42
•
•
•
•
•
Publication
20139972 | J:233134
First Author: Qiu T
Year: 2010
Journal: Nat Cell Biol
Title: TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Volume: 12
Issue: 3
Pages: 224-34
•
•
•
•
•
Publication
26977883 | J:231763
First Author: Wei D
Year: 2016
Journal: Cancer Cell
Title: KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis.
Volume: 29
Issue: 3
Pages: 324-38
•
•
•
•
•
Publication
20655471 | J:165982
First Author: Fulzele K
Year: 2010
Journal: Cell
Title: Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.
Volume: 142
Issue: 2
Pages: 309-19
•
•
•
•
•
Publication
30620636 | J:274021
First Author: Bethea M
Year: 2019
Journal: Am J Physiol Endocrinol Metab
Title: The islet-expressed Lhx1 transcription factor interacts with Islet-1 and contributes to glucose homeostasis.
Volume: 316
Issue: 3
Pages: E397-E409
•
•
•
•
•
Publication
23649480 | J:329848
First Author: Xia WF
Year: 2013
Journal: J Bone Miner Res
Title: Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
Volume: 28
Issue: 10
Pages: 2122-35
•
•
•
•
•
Publication
17785437 | J:129075
First Author: Zemljic-Harpf AE
Year: 2007
Journal: Mol Cell Biol
Title: Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy.
Volume: 27
Issue: 21
Pages: 7522-37
•
•
•
•
•
Publication
22982984 | J:205110
First Author: Frank M
Year: 2012
Journal: Circ Res
Title: Connexin45 provides optimal atrioventricular nodal conduction in the adult mouse heart.
Volume: 111
Issue: 12
Pages: 1528-38
•
•
•
•
•
Publication
17349581 | J:119990
First Author: Izeradjene K
Year: 2007
Journal: Cancer Cell
Title: Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
Volume: 11
Issue: 3
Pages: 229-43
•
•
•
•
•
Publication
30967626 | J:278171
First Author: Babicky ML
Year: 2019
Journal: Oncogene
Title: MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.
Volume: 38
Issue: 28
Pages: 5599-5611
•
•
•
•
•
Publication
21576357 | J:174096
First Author: Nakamura Y
Year: 2011
Journal: Mol Cell Biol
Title: Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling.
Volume: 31
Issue: 14
Pages: 3019-28
•
•
•
•
•
Publication
19899108 | J:161255
First Author: Shomento SH
Year: 2010
Journal: J Cell Biochem
Title: Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development.
Volume: 109
Issue: 1
Pages: 196-204
•
•
•
•
•
Publication
22071160 | J:178836
First Author: Yiannikouris F
Year: 2012
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.
Volume: 302
Issue: 2
Pages: R244-51
•
•
•
•
•
Publication
34037780 | J:306261
First Author: Kim CH
Year: 2021
Journal: Nucleic Acids Res
Title: NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development.
Volume: 49
Issue: 10
Pages: 5760-5778
•
•
•
•
•
Publication
22408025 | J:186570
First Author: Liu Y
Year: 2012
Journal: Am J Physiol Heart Circ Physiol
Title: Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.
Volume: 302
Issue: 9
Pages: H1860-70
•
•
•
•
•
Publication
27117420 | J:235385
First Author: Rabhi N
Year: 2016
Journal: Cell Rep
Title: KAT2B Is Required for Pancreatic Beta Cell Adaptation to Metabolic Stress by Controlling the Unfolded Protein Response.
Volume: 15
Issue: 5
Pages: 1051-1061
•
•
•
•
•
Publication
24621811 | J:215008
First Author: Nakamura Y
Year: 2014
Journal: PLoS One
Title: Targeting SUR1/Abcc8-type neuroendocrine KATP channels in pancreatic islet cells.
Volume: 9
Issue: 3
Pages: e91525
•
•
•
•
•
Publication
19015267 | J:145558
First Author: Carobbio S
Year: 2009
Journal: J Biol Chem
Title: Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.
Volume: 284
Issue: 2
Pages: 921-9
•
•
•
•
•
Publication
17591971 | J:122825
First Author: Zhu L
Year: 2007
Journal: Am J Pathol
Title: Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.
Volume: 171
Issue: 1
Pages: 263-73
•
•
•
•
•
Publication
36614194 | J:332519
 
First Author: Smith JP
Year: 2023
Journal: Int J Mol Sci
Title: Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression.
Volume: 24
Issue: 1
•
•
•
•
•
Publication
31068602 | J:279841
First Author: Leal AS
Year: 2019
Journal: Sci Rep
Title: The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in KrasG12D; Pdx1-Cre (KC) mice.
Volume: 9
Issue: 1
Pages: 7072
•
•
•
•
•
Publication
23912455 | J:212614
First Author: Dutruel C
Year: 2014
Journal: Oncogene
Title: Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Volume: 33
Issue: 26
Pages: 3401-10
•
•
•
•
•
Publication
30590101 | J:270061
 
First Author: Kibe S
Year: 2019
Journal: Cancer Lett
Title: Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion.
Volume: 444
Pages: 70-81
•
•
•
•
•
Publication
27758884 | J:238010
First Author: Driscoll DR
Year: 2016
Journal: Cancer Res
Title: mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.
Volume: 76
Issue: 23
Pages: 6911-6923
•
•
•
•
•
Publication
24395249 | J:205582
First Author: Saborowski M
Year: 2014
Journal: Genes Dev
Title: A modular and flexible ESC-based mouse model of pancreatic cancer.
Volume: 28
Issue: 1
Pages: 85-97
•
•
•
•
•
Publication
17909062 | J:125575
First Author: Clark CE
Year: 2007
Journal: Cancer Res
Title: Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
Volume: 67
Issue: 19
Pages: 9518-27
•
•
•
•
•
Publication
26156633 | J:225823
First Author: Martin D
Year: 2015
Journal: Dev Biol
Title: REST represses a subset of the pancreatic endocrine differentiation program.
Volume: 405
Issue: 2
Pages: 316-27
•
•
•
•
•
Publication
29339473 | J:257760
First Author: Nagaraj K
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.
Volume: 115
Issue: 5
Pages: 1045-1050
•
•
•
•
•
Publication
21952247 | J:179100
First Author: Plank JL
Year: 2011
Journal: Endocrinology
Title: Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy.
Volume: 152
Issue: 12
Pages: 4589-600
•
•
•
•
•
Publication
12215457 | J:80190
First Author: Zhang M
Year: 2002
Journal: J Biol Chem
Title: Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.
Volume: 277
Issue: 46
Pages: 44005-12
•
•
•
•
•
Publication
21731499 | J:307518
First Author: Leo L
Year: 2011
Journal: PLoS Genet
Title: Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.
Volume: 7
Issue: 6
Pages: e1002129
•
•
•
•
•
Publication
29606348 | J:260702
First Author: Li L
Year: 2018
Journal: Cancer Cell
Title: GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.
Volume: 33
Issue: 4
Pages: 736-751.e5
•
•
•
•
•
Publication
25584895 | J:219808
First Author: Wong PP
Year: 2015
Journal: Cancer Cell
Title: Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Volume: 27
Issue: 1
Pages: 123-37
•
•
•
•
•
Publication
24607504 | J:232076
First Author: Keenan BP
Year: 2014
Journal: Gastroenterology
Title: A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Volume: 146
Issue: 7
Pages: 1784-94.e6
•
•
•
•
•
Publication
28386018 | J:242294
First Author: Sinha S
Year: 2017
Journal: Cancer Res
Title: PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.
Volume: 77
Issue: 8
Pages: 1868-1879
•
•
•
•
•
Publication
23840665 | J:203716
First Author: Courtin A
Year: 2013
Journal: PLoS One
Title: Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Volume: 8
Issue: 6
Pages: e67330
•
•
•
•
•
Publication
28254412 | J:240391
 
First Author: Leal AS
Year: 2017
Journal: Cancer Lett
Title: Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.
Volume: 394
Pages: 76-87
•
•
•
•
•
Publication
27300433 | J:232330
First Author: DuFort CC
Year: 2016
Journal: Cancer Cell
Title: Tension and Transformation in Pancreas Cancer: Can Phenotype Break Free from the Chrysalis of Genotype?
Volume: 29
Issue: 6
Pages: 780-782
•
•
•
•
•
Publication
37190324 | J:335631
 
First Author: Yang D
Year: 2023
Journal: Cancers (Basel)
Title: Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis.
Volume: 15
Issue: 8
•
•
•
•
•
Publication
30930235 | J:274212
 
First Author: Fabian A
Year: 2019
Journal: Cancer Lett
Title: Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Volume: 453
Pages: 95-106
•
•
•
•
•
Publication
28315323 | J:325940
First Author: Jiang SH
Year: 2017
Journal: Gastroenterology
Title: Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Volume: 153
Issue: 1
Pages: 277-291.e19
•
•
•
•
•
Publication
28408354 | J:242491
 
First Author: Chen X
Year: 2017
Journal: Cancer Lett
Title: Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
Volume: 399
Pages: 20-28
•
•
•
•
•
Publication
28765154 | J:249042
First Author: D'Costa Z
Year: 2017
Journal: Cancer Res
Title: Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
Volume: 77
Issue: 21
Pages: 5952-5962
•
•
•
•
•
Publication
29621546 | J:271449
First Author: Cao XY
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Volume: 499
Issue: 3
Pages: 584-593
•
•
•
•
•
Publication
35752173 | J:354665
First Author: He D
Year: 2022
Journal: Mol Cell
Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.
Volume: 82
Issue: 16
Pages: 3045-3060.e11
•
•
•
•
•
Publication
27829137 | J:251957
First Author: Flint TR
Year: 2016
Journal: Cell Metab
Title: Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.
Volume: 24
Issue: 5
Pages: 672-684
•
•
•
•
•
Publication
26172047 | J:238533
First Author: Greco SH
Year: 2015
Journal: PLoS One
Title: TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Volume: 10
Issue: 7
Pages: e0132786
•
•
•
•
•
Publication
25368022 | J:218262
First Author: Sainz B Jr
Year: 2014
Journal: Cancer Res
Title: ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Volume: 74
Issue: 24
Pages: 7309-20
•
•
•
•
•
Publication
19460966 | J:149213
First Author: Olive KP
Year: 2009
Journal: Science
Title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Volume: 324
Issue: 5933
Pages: 1457-61
•
•
•
•
•
Publication
21403843 | J:171634
First Author: Fendrich V
Year: 2011
Journal: Neoplasia
Title: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Volume: 13
Issue: 2
Pages: 180-6
•
•
•
•
•
Publication
36919330 | J:335589
First Author: He F
Year: 2023
Journal: Cancer Res
Title: FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.
Volume: 83
Issue: 10
Pages: 1628-1645
•
•
•
•
•
Publication
32156729 | J:286585
First Author: Wasylishen AR
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.
Volume: 117
Issue: 12
Pages: 6622-6629
•
•
•
•
•
Publication
21242978 | J:173715
First Author: Shields DJ
Year: 2011
Journal: Oncogene
Title: Oncogenic Ras/Src cooperativity in pancreatic neoplasia.
Volume: 30
Issue: 18
Pages: 2123-34
•
•
•
•
•
Publication
26144316 | J:224529
First Author: Palm W
Year: 2015
Journal: Cell
Title: The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Volume: 162
Issue: 2
Pages: 259-270
•
•
•
•
•
Publication
28757253 | J:252097
First Author: Roe JS
Year: 2017
Journal: Cell
Title: Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Volume: 170
Issue: 5
Pages: 875-888.e20
•
•
•
•
•
Publication
35561453 | J:325347
 
First Author: Jiang SH
Year: 2022
Journal: EBioMedicine
Title: Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
Volume: 80
Pages: 104050
•
•
•
•
•
Publication
28453537 | J:245950
First Author: Kersemans V
Year: 2017
Journal: PLoS One
Title: An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.
Volume: 12
Issue: 4
Pages: e0176693
•
•
•
•
•
Publication
29135982 | J:252226
First Author: Baird JR
Year: 2017
Journal: PLoS One
Title: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
Volume: 12
Issue: 11
Pages: e0187532
•
•
•
•
•
Publication
31330317 | J:293294
First Author: Gao C
Year: 2019
Journal: Cell Mol Gastroenterol Hepatol
Title: PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654.
Volume: 8
Issue: 4
Pages: 561-578
•
•
•
•
•
Publication
31413817 | J:317025
First Author: Strand MS
Year: 2019
Journal: Oncotarget
Title: Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles.
Volume: 10
Issue: 46
Pages: 4761-4775
•
•
•
•
•
Publication
35235808 | J:325480
First Author: Shields MA
Year: 2022
Journal: Cell Rep
Title: Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin.
Volume: 38
Issue: 9
Pages: 110441
•
•
•
•
•
Publication
23963802 | J:303013
First Author: Husain K
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Volume: 6
Issue: 10
Pages: 1074-83
•
•
•
•
•
Publication
27489361 | J:236853
First Author: GrĂĽnwald B
Year: 2016
Journal: Mol Cancer Res
Title: Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
Volume: 14
Issue: 11
Pages: 1147-1158
•
•
•
•
•
Publication
24336331 | J:218641
First Author: KĂĽhnemuth B
Year: 2015
Journal: Oncogene
Title: CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-ÎşB signaling.
Volume: 34
Issue: 2
Pages: 177-87
•
•
•
•
•
Publication
30863319 | J:309716
 
First Author: Li C
Year: 2019
Journal: Front Physiol
Title: MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Volume: 10
Pages: 147
•
•
•
•
•
Publication
38902362 | J:352006
First Author: Jacobson R
Year: 2024
Journal: Sci Rep
Title: Differential extracellular vesicle concentration and their biomarker expression of integrin α(v)/β(5), EpCAM, and glypican-1 in pancreatic cancer models.
Volume: 14
Issue: 1
Pages: 14273
•
•
•
•
•
Publication
37255660 | J:347476
First Author: Kaune T
Year: 2023
Journal: iScience
Title: Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
Volume: 26
Issue: 6
Pages: 106841
•
•
•
•
•
Publication
29050937 | J:253991
First Author: Jiang S
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Volume: 494
Issue: 1-2
Pages: 113-119
•
•
•
•
•
Publication
23887057 | J:202529
First Author: Shen R
Year: 2013
Journal: Cancer Lett
Title: The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Volume: 339
Issue: 1
Pages: 135-43
•
•
•
•
•
Publication
23689354 | J:200524
First Author: Li H
Year: 2013
Journal: Carcinogenesis
Title: Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
Volume: 34
Issue: 9
Pages: 2090-8
•
•
•
•
•
Publication
29414775 | J:262781
First Author: Maity G
Year: 2018
Journal: J Biol Chem
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Volume: 293
Issue: 12
Pages: 4334-4349
•
•
•
•
•
Publication
29567829 | J:260710
First Author: Pushalkar S
Year: 2018
Journal: Cancer Discov
Title: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Volume: 8
Issue: 4
Pages: 403-416
•
•
•
•
•
Publication
34922945 | J:322176
First Author: Costamagna A
Year: 2022
Journal: Gastroenterology
Title: Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Volume: 162
Issue: 4
Pages: 1242-1255.e11
•
•
•
•
•
Publication
33110235 | J:301792
First Author: Nimmakayala RK
Year: 2021
Journal: Oncogene
Title: Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Volume: 40
Issue: 1
Pages: 215-231
•
•
•
•
•
Publication
26310823 | J:224975
 
First Author: Schneider P
Year: 2015
Journal: Nat Commun
Title: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Volume: 6
Pages: 8023
•
•
•
•
•
Publication
27061193 | J:241175
First Author: Carapuça EF
Year: 2016
Journal: J Pathol
Title: Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.
Volume: 239
Issue: 3
Pages: 286-96
•
•
•
•
•
Publication
32580961 | J:296304
First Author: Wang F
Year: 2020
Journal: Cancer Res
Title: p38Îł MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Volume: 80
Issue: 16
Pages: 3251-3264
•
•
•
•
•
Publication
29222037 | J:253809
 
First Author: Rahn S
Year: 2018
Journal: Cancer Lett
Title: Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Volume: 415
Pages: 129-150
•
•
•
•
•
Publication
22351932 | J:182504
First Author: Cook N
Year: 2012
Journal: J Exp Med
Title: Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma.
Volume: 209
Issue: 3
Pages: 437-44
•
•
•
•
•
Publication
35626052 | J:349029
 
First Author: Natarajan V
Year: 2022
Journal: Cancers (Basel)
Title: Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma.
Volume: 14
Issue: 10
•
•
•
•
•
Publication
31815046 | J:349040
First Author: Yang J
Year: 2019
Journal: Am J Cancer Res
Title: Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Volume: 9
Issue: 11
Pages: 2456-2468
•
•
•
•
•
Publication
35219699 | J:349104
First Author: Ganguly K
Year: 2022
Journal: Gastroenterology
Title: Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
Volume: 162
Issue: 7
Pages: 2032-2046.e12
•
•
•
•
•
Publication
31369062 | J:290838
First Author: Mendez R
Year: 2020
Journal: Carcinogenesis
Title: Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Volume: 41
Issue: 5
Pages: 561-570
•
•
•
•
•
Publication
27248578 | J:349079
 
First Author: Lee JW
Year: 2016
Journal: Curr Protoc Pharmacol
Title: Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
Volume: 73
Pages: 14.39.1-14.39.20
•
•
•
•
•
Publication
32251410 | J:349151
First Author: Ferguson FM
Year: 2020
Journal: Nat Chem Biol
Title: Discovery of a selective inhibitor of doublecortin like kinase 1.
Volume: 16
Issue: 6
Pages: 635-643
•
•
•
•
•
Publication
31433988 | J:299226
First Author: Burrack AL
Year: 2019
Journal: Cell Rep
Title: Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 8
Pages: 2140-2155.e6
•
•
•
•
•
Publication
29367759 | J:261029
First Author: Fendrich V
Year: 2018
Journal: Oncogene
Title: Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Volume: 37
Issue: 14
Pages: 1845-1856
•
•
•
•
•
Publication
27919787 | J:239396
 
First Author: Garg B
Year: 2017
Journal: Cancer Lett
Title: Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
Volume: 388
Pages: 64-72
•
•
•
•
•
Publication
30086262 | J:311766
First Author: Chugh S
Year: 2018
Journal: Gastroenterology
Title: Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Volume: 155
Issue: 5
Pages: 1608-1624
•
•
•
•
•
Publication
28024083 | J:254380
First Author: Davidson SM
Year: 2017
Journal: Nat Med
Title: Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Volume: 23
Issue: 2
Pages: 235-241
•
•
•
•
•
Publication
27624879 | J:254486
 
First Author: Verma RK
Year: 2016
Journal: Sci Rep
Title: α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Volume: 6
Pages: 32743
•
•
•
•
•
Publication
30008881 | J:299376
First Author: Noguchi K
Year: 2018
Journal: Oncol Lett
Title: c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.
Volume: 16
Issue: 2
Pages: 1892-1898
•
•
•
•
•
Publication
25557080 | J:219289
First Author: Boj SF
Year: 2015
Journal: Cell
Title: Organoid models of human and mouse ductal pancreatic cancer.
Volume: 160
Issue: 1-2
Pages: 324-38
•
•
•
•
•
Publication
22585996 | J:193075
First Author: Frese KK
Year: 2012
Journal: Cancer Discov
Title: nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Volume: 2
Issue: 3
Pages: 260-269
•
•
•
•
•
Publication
29259015 | J:261887
First Author: Dauer P
Year: 2018
Journal: Cancer Res
Title: Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Volume: 78
Issue: 5
Pages: 1321-1333
•
•
•
•
•
Publication
26077591 | J:233548
First Author: Miller BW
Year: 2015
Journal: EMBO Mol Med
Title: Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Volume: 7
Issue: 8
Pages: 1063-76
•
•
•
•
•
Publication
33537098 | J:308811
First Author: Lee JS
Year: 2021
Journal: Theranostics
Title: Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse.
Volume: 11
Issue: 7
Pages: 3472-3488
•
•
•
•
•
Publication
33127746 | J:301318
First Author: Ganguly K
Year: 2021
Journal: Cancer Res
Title: Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
Volume: 81
Issue: 1
Pages: 91-102
•
•
•
•
•
Publication
31534627 | J:298180
First Author: Ueda Y
Year: 2019
Journal: Oncotarget
Title: Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice.
Volume: 10
Issue: 52
Pages: 5412-5418
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom